MedTrace Logo

Multiplex Analysis of Circulating Tumor DNA

NCT03301961 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-02-05

No results posted yet for this study

Summary

Lung cancer is the leading cause of cancer-related death in China. This study will explore the applications of multiplex analysis of circulating tumor DNA biomarkers for diagnosis and surveillance of lung cancer patients

Conditions

  • Carcinoma
  • Non-small-cell Lung Cancer
  • Lung Neoplasm

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Kezhong Chen, MD · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-11
Primary Completion
2020-06-01
Completion
2022-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03301961 on ClinicalTrials.gov